147 related articles for article (PubMed ID: 1677313)
41. Effects of isoprenaline, adrenaline and selective alpha 1- and alpha 2- adrenoceptor stimulation on hypoxic pulmonary vasoconstriction in rat isolated perfused lungs.
Piercy V; Smith H; Arch JR
Pulm Pharmacol; 1990; 3(2):59-63. PubMed ID: 1983734
[TBL] [Abstract][Full Text] [Related]
42. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro.
Umetsu T; Sanai K; Kato T
Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593
[TBL] [Abstract][Full Text] [Related]
43. Potentiation by alpha and inhibition by beta-adrenergic stimulations of rat platelet aggregation. A comparative study with human and rabbit platelets.
Yu SK; Latour JG
Thromb Haemost; 1977 Jun; 37(3):413-22. PubMed ID: 578021
[TBL] [Abstract][Full Text] [Related]
44. Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.
Kerry R; Scrutton MC
Br J Pharmacol; 1983 Jun; 79(2):401-7. PubMed ID: 6140040
[TBL] [Abstract][Full Text] [Related]
45. Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.
Nakaki T; Nakadate T; Yamamoto S; Kato R
Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):181-4. PubMed ID: 6121295
[TBL] [Abstract][Full Text] [Related]
46. The effects of chronic administration of adrenaline on the function and number of adrenoceptors in the rabbit.
Deighton NM; Hamilton CA; Jones CR; Reid JL
J Cardiovasc Pharmacol; 1988 Sep; 12(3):332-7. PubMed ID: 2464106
[TBL] [Abstract][Full Text] [Related]
47. Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell.
Vieira E; Liu YJ; Gylfe E
Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):179-83. PubMed ID: 14727006
[TBL] [Abstract][Full Text] [Related]
48. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
49. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
[TBL] [Abstract][Full Text] [Related]
50. Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro.
Larsson PT; Wallén NH; Martinsson A; Egberg N; Hjemdahl P
Thromb Haemost; 1992 Dec; 68(6):687-93. PubMed ID: 1337630
[TBL] [Abstract][Full Text] [Related]
51. Epinephrine induced platelet aggregation in rat platelet-rich plasma.
Yun-Choi HS; Park KM; Pyo MK
Thromb Res; 2000 Dec; 100(6):511-8. PubMed ID: 11152931
[TBL] [Abstract][Full Text] [Related]
52. Characterisation of human platelet adrenoceptors.
Barnett DB; Swart SS; Nahorski SR; Cook N
Adv Exp Med Biol; 1985; 192():97-108. PubMed ID: 2871708
[No Abstract] [Full Text] [Related]
53. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
Milton JG; Frojmovic MM
J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
[TBL] [Abstract][Full Text] [Related]
54. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
Alarayyed NA; Graham BR; Prichard BN; Smith CC
Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
[TBL] [Abstract][Full Text] [Related]
55. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
Thiemermann C; May GR; Page CP; Vane JR
Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
[TBL] [Abstract][Full Text] [Related]
56. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.
Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL
Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850
[TBL] [Abstract][Full Text] [Related]
57. Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
Hamilton CA; Deighton NM; Reid JL
Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):534-40. PubMed ID: 2886922
[TBL] [Abstract][Full Text] [Related]
58. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
Williamson KL; Broadley KJ
Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
[TBL] [Abstract][Full Text] [Related]
59. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jones CR; Pasanisi F; Elliott HL; Reid JL
Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
[TBL] [Abstract][Full Text] [Related]
60. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
Steen VM; Holmsen H; Aarbakke G
Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
